Transition Therapeutics, Juvenile Diabetes Research Foundation International deal

Transition disclosed in its 1Q09 earnings that the foundation and the company mutually agreed to terminate their 2006 deal for the foundation to help fund development of Transition's TT-223 (formerly ...